Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 21, 2020; 26(15): 1733-1744
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1733
Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1733
Ref. | Country | X-line | Publication year | Drug combination (per day) | Duration (d) | Eradication rate (%) | |
ITT | PP | ||||||
Cheon et al[70] | South Korea | 2nd | 2006 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 7 | 75.6 | 83.8 |
Kang et al[71] | South Korea | 2nd | 2007 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 10 | 71.9 | 82.6 |
Bago et al[72] | Croatia | 2nd | 2009 | MOFX 400 mg + MTZ 1500 mg + OPZ 40 mg | 7 | 73.2 | 78.9 |
Yoon et al[73] | South Korea | 2nd | 2009 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 7 | 75.6 | 83.8 |
Yoon et al[73] | South Korea | 2nd | 2009 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 10 | 71.9 | 82.6 |
Yoon et al[73] | South Korea | 2nd | 2009 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 14 | 68.0 | 79.9 |
Miehlke et al[74] | Germany | 2nd and more | 2011 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 7 | 78.9 | 78.9 |
Miehlke et al[74] | Germany | 2nd and more | 2011 | MOFX 400 mg + AMX 2000 mg + EPZ 40 mg | 14 | 95.0 | 94.4 |
Kang et al[75] | South Korea | 2nd | 2014 | MOFX 400 mg + AMX 2000 mg + RPZ 20 mg | 7 | 58.0 | 62.5 |
Kang et al[75] | South Korea | 2nd | 2014 | MOFX 400 mg + AMX 2000 mg + RPZ 20 mg | 14 | 71.8 | 77.5 |
Chung et al[77] | South Korea | 2nd | 2014 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 7 | 62.7 | 62.7 |
Lee et al[76] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + PPI | 7 | 53.1 | 55.6 |
Lee et al[76] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + PPI | 14 | 73.5 | 80.6 |
Hwang et al[78] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 7 | 70.8 | 77.7 |
Hwang et al[78] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 14 | 81.4 | 90.4 |
Lim et al[79] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 7 | 56.7 | 59.6 |
Lim et al[79] | South Korea | 2nd | 2015 | MOFX 400 mg + AMX 2000 mg + RPZ 40 mg | 14 | 76.3 | 80.6 |
Marušić et al[81] | Croatia | 2nd | 2017 | MOFX 400 mg + MTZ 1000 mg + Bismuth 480 mg + PPZ 80 mg | 14 | 80.6 | 88.0 |
- Citation: Mori H, Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol 2020; 26(15): 1733-1744
- URL: https://www.wjgnet.com/1007-9327/full/v26/i15/1733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i15.1733